{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:34:06Z","timestamp":1772174046294,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":140,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RF-2018-12365391"],"award-info":[{"award-number":["RF-2018-12365391"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.talanta.2023.124392","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T12:16:10Z","timestamp":1677240970000},"page":"124392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Determination of endocannabinoids and their conjugated congeners in the brain by means of \u03bcSPE combined with UHPLC-MS\/MS"],"prefix":"10.1016","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9235-5874","authenticated-orcid":false,"given":"Federico","family":"Fanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-880X","authenticated-orcid":false,"given":"Flaminia","family":"Vincenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Imparato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7721-4961","authenticated-orcid":false,"given":"Camilla","family":"Montesano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Scipioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ciaramellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Tortolani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Oddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Maccarrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Compagnone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Sergi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2023.124392_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1474-4422(19)30032-8","article-title":"Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders","volume":"18","author":"Friedman","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.talanta.2023.124392_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.talanta.2023.124392_bib3","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s42255-022-00600-1","article-title":"Metabolic messengers: endocannabinoids","volume":"4","author":"Busquets-Garcia","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.talanta.2023.124392_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molmed.2019.11.002","article-title":"Missing pieces to the endocannabinoid puzzle","volume":"26","author":"Maccarrone","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.talanta.2023.124392_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2020.06.028","article-title":"Bioactive lipids, inflammation and chronic diseases","volume":"159","author":"Leuti","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.talanta.2023.124392_bib6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd.2018.115","article-title":"New approaches and challenges to targeting the endocannabinoid system","volume":"17","author":"Di Marzo","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.talanta.2023.124392_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2091-10-14","article-title":"The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways","volume":"10","author":"Bradshaw","year":"2009","journal-title":"BMC Biochem."},{"key":"10.1016\/j.talanta.2023.124392_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2003.12.075","article-title":"A structure-activity relationship study on N -arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase","volume":"314","author":"Cascio","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.talanta.2023.124392_bib9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1042\/bj3510817","article-title":"N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo","volume":"351","author":"Bisogno","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.talanta.2023.124392_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0960-894X(00)00689-2","article-title":"Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine","volume":"11","author":"Bezuglov","year":"2001","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.talanta.2023.124392_bib11","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","volume":"99","author":"Huang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.talanta.2023.124392_bib12","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/j.1476-5381.2010.00841.x","article-title":"Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator","volume":"160","author":"Zhang","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.talanta.2023.124392_bib13","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1073\/pnas.0510676103","article-title":"N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties","volume":"103","author":"Milman","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.talanta.2023.124392_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.prostaglandins.2006.08.002","article-title":"Quantification of endocannabinoids in rat biological samples by GC\/MS: technical and theoretical considerations","volume":"81","author":"Hardison","year":"2006","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.talanta.2023.124392_bib15","first-page":"883","article-title":"Simultaneous UPLC-MS\/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG\/1AG isomerization and degradation by toluene solvent extractio","author":"Zoerner","year":"2012","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2023.124392_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jchromb.2011.02.004","article-title":"Determination of endocannabinoids in nematodes and human brain tissue by liquid chromatography electrospray ionization tandem mass spectrometry","volume":"879","author":"Lehtonen","year":"2011","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2023.124392_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jchromb.2014.03.019","article-title":"Simultaneous ultra-high performance liquid chromathograpy-electrospray ionization-quadrupole-time of flight mass spectrometry quantification of endogenous anandamide and related N-acylethanolamides in bio-matrices","volume":"958","author":"Ottria","year":"2014","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2023.124392_bib18","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1021\/ac403352e","article-title":"Development and validation of a sensitive UPLC-ESI-MS\/MS method for the simultaneous quantification of 15 endocannabinoids and related compounds in milk and other biofluids","volume":"86","author":"Gouveia-Figueira","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2023.124392_bib19","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1194\/jlr.D094680","article-title":"Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds, and their phospholipid precursors in human plasma by UHPLC-MS\/MS","volume":"60","author":"R\u00f6hrig","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.talanta.2023.124392_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00216-012-6273-3","article-title":"Determination of the two major endocannabinoids in human plasma by \u03bc-SPE followed by HPLC-MS\/MS","volume":"405","author":"Sergi","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2023.124392_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ab.2012.09.031","article-title":"Quantitative LC-MS\/MS analysis of arachidonoyl amino acids in mouse brain with treatment of FAAH inhibitor","volume":"432","author":"Han","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.talanta.2023.124392_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jpha.2013.11.004","article-title":"Quantification of anandamide, oleoylethanolamide and palmitoylethanolamide in rodent brain tissue using high performance liquid chromatography-electrospray mass spectroscopy","volume":"4","author":"Liput","year":"2014","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.talanta.2023.124392_bib23","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.3390\/ijms20184503","article-title":"Different routes to inhibit fatty acid amide hydrolase: do all roads lead to the same place?","volume":"20","author":"Giacovazzo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.talanta.2023.124392_bib24","series-title":"ICH Guideline M10 on Bioanalytical Method Validation","year":"2019"},{"key":"10.1016\/j.talanta.2023.124392_bib25","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1039\/C4AY00915K","article-title":"A review of sample preparation methods for quantitation of small-molecule analytes in brain tissue by liquid chromatography tandem mass spectrometry (LC-MS\/MS)","volume":"6","author":"Li","year":"2014","journal-title":"Anal. Methods"},{"key":"10.1016\/j.talanta.2023.124392_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121393","article-title":"Quantitative analysis of oxysterols in zebrafish embryos by HPLC-MS\/MS","volume":"220","author":"Fanti","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2023.124392_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113302","article-title":"dLLME-\u03bcSPE extraction coupled to HPLC-ESI-MS\/MS for the determination of F2\u03b1-IsoPs in human urine","volume":"186","author":"Fanti","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.talanta.2023.124392_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114181","article-title":"\u03bcSPE followed by HPLC\u2013MS\/MS for the determination of series D and E resolvins in biological matrices","volume":"203","author":"Fanti","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.talanta.2023.124392_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.talanta.2017.02.019","article-title":"Application of a rapid \u03bc-SPE clean-up for multiclass quantitative analysis of sixteen new psychoactive substances in whole blood by LC-MS\/MS","volume":"167","author":"Montesano","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2023.124392_bib30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.trac.2008.09.002","article-title":"Quantitative determination of endogenous compounds in biological samples using chromatographic techniques","volume":"27","author":"van de Merbel","year":"2008","journal-title":"TrAC, Trends Anal. Chem."},{"key":"10.1016\/j.talanta.2023.124392_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1471-4159.2001.00413.x","article-title":"Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages","volume":"78","author":"Maccarrone","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.talanta.2023.124392_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/jnc.12495","article-title":"Brain region-specific changes in N-acylethanolamine contents with time of dayJ","volume":"128","author":"Liedhegner","year":"2014","journal-title":"Neurochem"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914023001431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914023001431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T13:09:13Z","timestamp":1758546553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914023001431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":32,"alternative-id":["S0039914023001431"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2023.124392","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of endocannabinoids and their conjugated congeners in the brain by means of \u03bcSPE combined with UHPLC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2023.124392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"124392"}}